Drug Shortage Report for SANDOZ LOSARTAN HCT

Last updated on 2023-05-03 History
Report ID 145346
Drug Identification Number 02313375
Brand name SANDOZ LOSARTAN HCT
Common or Proper name LOSARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30FCT UD
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-09-08
Estimated end date 2023-04-28
Actual end date 2023-05-01
Shortage status Resolved
Updated date 2023-05-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-05-03 English Compare
v11 2023-05-01 French Compare
v10 2023-05-01 English Compare
v9 2023-03-13 French Compare
v8 2023-03-13 English Compare
v7 2022-11-16 French Compare
v6 2022-11-16 English Compare
v5 2022-10-26 French Compare
v4 2022-10-26 English Compare
v3 2021-09-09 English Compare
v2 2021-09-08 French Compare
v1 2021-09-08 English Compare

Showing 1 to 12 of 12